54 results
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Management of Antirheumatic ... Medication in Patients ... #rheumatology #medications ... #management #autoimmune
Management of type 2 diabetes in adults: summary of updated NICE guidance
#diabetes #type2 #DM2 #management #NICE
Management of type ... diabetes #type2 #DM2 #management ... #NICE #guidelines ... #medications #insulin
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... COVID-19 Specific Medications ... #criticalcare #Guidelines ... NonIntensivist #diagnosis #management
Multiple Uses for Tranexamic Acid (TXA) - Evidence Based Indications and Dosing

Trauma < 3 hrs •
Evidence Based Indications ... TranexamicAcid #Indications ... #management #EBM
Management of Medically Refractory Gastroparesis

Gastroparesis Pathophysiology
Initial Evaluation
Management
Medications for Medically Refractory Gastroparesis
Gastric Electrical Stimulation
Pylorus Directed Therapies

Dr. Chaitanya
Management of Medically ... Initial Evaluation Management ... Medications for ... Gastroparesis #Refractory #Management ... #Treatment #Gastroenterology
Probiotics in Gastrointestinal Diseases

#Probiotics #ebm #indications #management #algorithm #gastroenterology
#Probiotics #ebm ... #indications #management ... #algorithm #gastroenterology
PocketPEM - Resus Meds
#Management #Pharm	#Peds #EM	#Resus #Medications #ResusMeds #Resuscitation #PocketCard #PocketPEM
- Resus Meds #Management ... #Pharm #Peds #EM ... #Resus #Medications
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Effect Sites and Indications ... #Pathophys #Management ... #EM #IM #PCC #Catecholamine
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... for the Management ... 5.2 and 5.4 #EBM ... #Management #Pharmacology ... Personality #Disorder #Medications
Guidelines on De-Prescribing of Proton Pump Inhibitors

Best Practice Advice Statements
Long-term Indications for PPI use
Short-term Indications for
Guidelines on De-Prescribing ... Statements Long-term Indications ... use Short-term Indications ... Inhibitors #PPI #Guidelines ... #management #gastroenterology